1. Executive Summary 2. China IVD Market and Market Share Analysis (2014 - 2030) 2.1 China IVD Market and Forecast 2.2 China IVD Market Share and Forecast - By Segment 2.3 China IVD Market Share and Forecast - By Company 3. China IVD - Segments Wise Market and Forecast (2014 - 2030) 3.1 China Clinical Chemistry Market and Forecast 3.2 China Immunoassay Market and Forecast 3.3 China Hematology Market and Forecast 3.4 China Coagulation Market and Forecast 3.5 China Microbiology Market and Forecast 3.6 China Molecular Testing Market and Forecast 3.7 China Self-Monitoring of Blood Glucose (SMBG) Market and Forecast 3.8 China Point of Care Testing (POCT) Market and Forecast 4. Development Environment of Chinese IVD Industry 4.1 State Healthcare Reforms 4.2 State Citizen-Benefiting Policies 4.3 Requirements of Hospital Upgrading 4.4 Healthy China 2030 5. Profile of In-vitro Diagnostic Reagents Registration Control 5.1 Classification of In-vitro Diagnostic Reagents in China 5.1.1 Class III: Highest Risk 5.1.2 Class II: Medium Risk 5.1.3 Class I: Lower Risk 5.2 Regulatory History in China IVD Market 5.3 Regulatory Status in China IVD Market 5.3.1 Blood Screening Reagents - Drug Administration 5.3.2 Varieties of Blood Screening Reagents 5.3.3 Blood Screening Reagent Test 5.3.4 Nucleic Acid Detection Kits for Blood Screening 5.3.5 Radioactive reagents - Drug Administration 5.3.6 Diagnostic Reagents - Medical Devices Management 5.4 Regulatory Trend in China IVD Market 5.4.1 Blood Screening Reagents Belonging 5.4.2 Quality Improvement 5.4.3 Pre-Evaluation of Registration Standards 6. Registration for In Vitro Diagnostic Reagents in China 6.1 Registration and Filing 6.2 Filing Obligation for Clinical Trials 6.3 Clinical Trial Institutions 6.4 Elimination of IVD Loophole for Research 6.5 Change of Manufacturing Address 6.6 Change of Main Supplier of An Antigen or Antibody 6.7 China In Vitro Diagnostics Registration Update 6.7.1 IVD Product Registration in China 6.7.2 China IVD Type Testing Process 6.7.3 Clinical Trials for IVD Products in China 7. Reimbursement of IVD Products in China 8. China IVD Market - Key Players Sales Analysis (2015 - 2030) 8.1 Roche Diagnostics 8.1.1 Company Overview 8.1.2 Roche Diagnostics - China IVD Sales and Forecast 8.1.3 Recent Developments 8.2 Abbott Laboratories 8.2.1 Company Overview 8.2.2 Abbott Laboratories - China IVD Sales and Forecast 8.2.3 Recent Developments 8.3 Sysmex Corporation 8.3.1 Company Overview 8.3.2 Sysmex Corporation - China IVD Sales and Forecast 8.3.3 Recent Developments 8.4 Mindray Medical International Limited 8.4.1 Company Overview 8.4.2 Mindray Medical International Limited - China IVD Sales and Forecast 8.4.3 Recent Developments 8.5 Shanghai Kehua Bio-Engineering Co. Ltd. 8.5.1 Business Overview 8.5.2 Shanghai Kehua Bio-Engineering Co. Ltd. - China IVD Sales & Forecast 8.5.3 Recent Developments 8.6 bioMérieux S.A. 8.6.1 Business Overview 8.6.2 bioMérieux SA - China IVD Sales & Forecast 8.6.3 Recent Developments 8.7 Bio-Rad Laboratories, Inc. 8.7.1 Company Overview 8.7.2 Bio-Rad Laboratories, Inc. - China IVD Sales & Forecast 8.7.3 Recent Developments 8.8 Danaher Corporation 8.8.1 Company Overview 8.8.2 Danaher Corporation - China IVD Sales & Forecast 8.8.3 Recent Developments 8.9 Thermo Fisher Scientific Inc. 8.9.1 Company Overview 8.9.2 Thermo Fisher Scientific Inc. - China IVD Sales & Forecast 8.9.3 Recent Developments 8.10 Snibe Diagnostic 8.10.1 Company Overview 8.10.2 Snibe Diagnostic - Global IVD Sales 8.10.3 Recent Developments 8.11 Dirui Medical 8.11.1 Company Overview 8.11.2 Dirui Medical - Global Sales 8.12 Autobio Diagnostics 8.12.1 Company Overview 8.12.2 Autobio Diagnostics - Global Sales 8.12.3 Recent Developments 8.13 YHLO Biotech 8.13.1 Company Overview 8.13.2 YHLO Biotech – Global Sales 8.13.3 Recent Developments 8.14 Beijing Strong Biotechnologies, Inc. 8.14.1 Company Overview 8.14.2 Beijing Strong Biotechnologies, Inc. - China IVD Sales 8.14.3 Recent Developments 8.15 Others - China IVD Sales and Forecast 9. Profiles of Select Clinical Labs and Diagnostic Services Companies 9.1 Dian Diagnostics Group Co. Ltd. (Formerly Zhejiang Di’an Diagnostics Technology Co., Ltd.) 9.1.1 Company Overview 9.1.2 Products and Services Offered by Di’an 9.2 ADICON Clinical Laboratories 9.2.1 Company Overview 9.2.2 Products and Services Offered by ADICON 9.3 Guangzhou KingMed Diagnostics Center Co. Ltd. 9.3.1 Company Overview 9.3.2 Products and Services Offered by KingMed 9.4 Kindstar Global 9.4.1 Company Overview 9.4.2 Products and Services Offered by Kindstar 9.5 BGI Group 9.5.1 Company Overview 9.6 OriGene Technologies 9.6.1 Company Overview 9.6.2 Products and Services Offered by OriGene 10. In-Vitro Diagnostics (IVD) Market - Major Deals 11. In-Vitro Diagnostics (IVD) Market - Recent Developments 12. China In–Vitro Diagnostics – Market Dynamics 12.1 China IVD Market - Driving Factors 12.2 China IVD Market - Challenges

List of Figures: Figure 2-1: China - IVD Market (Million US$), 2014 - 2023 Figure 2-2: China - Forecast for IVD Market (Million US$), 2024 - 2030 Figure 3-1: China - Clinical Chemistry Market (Million US$), 2014 - 2023 Figure 3-2: China - Forecast for Clinical Chemistry Market (Million US$), 2024 - 2030 Figure 3-3: China - Immunoassay Market (Million US$), 2014 - 2023 Figure 3-4: China - Forecast for Immunoassay Market (Million US$), 2024 - 2030 Figure 3-5: China - Hematology Market (Million US$), 2014 - 2023 Figure 3-6: China - Forecast for Hematology Market (Million US$), 2024 - 2030 Figure 3-7: China - Coagulation Market (Million US$), 2014 - 2023 Figure 3-8: China - Forecast for Coagulation Market (Million US$), 2024 - 2030 Figure 3-9: China - Microbiology Market (Million US$), 2014 - 2023 Figure 3-10: China - Forecast for Microbiology Market (Million US$), 2024 - 2030 Figure 3-11: China - Molecular Testing Market (Million US$), 2014 - 2023 Figure 3-12: China - Forecast for Molecular Testing Market (Million US$), 2024 - 2030 Figure 3-13: China - SMBG Market (Million US$), 2014 - 2023 Figure 3-14: China - Forecast for SMBG Market (Million US$), 2024 - 2030 Figure 3-15: China - POCT Market (Million US$), 2014 - 2023 Figure 3-16: China - Forecast for POCT Market (Million US$), 2024 - 2030 Figure 8-1: Roche Diagnostics - China IVD Revenue (Million US$), 2015 - 2023 Figure 8-2: Roche Diagnostics - Forecast for China IVD Revenue (Million US$), 2024 - 2030 Figure 8-3: Abbott Laboratories - China IVD Revenue (Million US$), 2015 - 2023 Figure 8-4: Abbott Laboratories - Forecast for China IVD Revenue (Million US$), 2024 - 2030 Figure 8-5: Sysmex Corporation - China IVD Revenue (Million US$), 2015 - 2023 Figure 8-6: Sysmex Corporation - Forecast for China IVD Revenue (Million US$), 2024 - 2030 Figure 8-7: Mindray Medical - China IVD Revenue (Million US$), 2015 - 2023 Figure 8-8: Mindray Medical - Forecast for China IVD Revenue (Million US$), 2024 - 2030 Figure 8-9: Shanghai Kehua - China IVD Revenue (Million US$), 2015 - 2023 Figure 8-10: Shanghai Kehua - Forecast for China IVD Revenue (Million US$), 2024 - 2030 Figure 8-11: bioMérieux SA - China IVD Revenue (Million US$), 2015 - 2023 Figure 8-12: bioMérieux SA - Forecast for China IVD Revenue (Million US$), 2024 - 2030 Figure 8-13: Bio-Rad Laboratories, Inc. - China IVD Revenue (Million US$), 2015 - 2023 Figure 8-14: Bio-Rad Laboratories, Inc. - Forecast for China IVD Revenue (Million US$), 2024 - 2030 Figure 8-15: Danaher Corporation - China IVD Revenue (Million US$), 2015 - 2023 Figure 8-16: Danaher Corporation - Forecast for China IVD Revenue (Million US$), 2024 - 2030 Figure 8-17: Thermo Fisher Scientific Inc. - China IVD Revenue (Million US$), 2015 - 2023 Figure 8-18: Thermo Fisher Scientific Inc. - Forecast for China IVD Revenue (Million US$), 2024 - 2030 Figure 8-19: Snibe Diagnostic - Global IVD Revenue (Million US$), 2018 – 2023e Figure 8-20: Dirui Medical - Global Revenue (Million US$), 2019 – 2023e Figure 8-21: Autobio Diagnostics - Global Revenue (Million US$), 2018 – 2023e Figure 8-22: YHLO Biotech - Global Revenue (Million US$), 2019 – 2023e Figure 8-23: Beijing Strong Biotechnologies, Inc. – China IVD Revenue (Million US$), 2018 – 2023e Figure 8-24: Others - China IVD Revenue (Million US$), 2015 - 2023 Figure 8-25: Others - Forecast for China IVD Revenue (Million US$), 2024 - 2030 List of Tables: Table 2-1: China - IVD Market Share (Percent), 2014 - 2023 Table 2-2: China - Forecast for IVD Market Share (Percent), 2024 - 2030 Table 2-3: China IVD Market - Company Share (Percent), 2015 - 2023 Table 2-4: China IVD Market - Forecast for Company Share (Percent), 2024 - 2030 Table 12-1: China Food and Drug Administration - Regulation and Impact for Medical Device and IVD Manufacturers Selling in China

1. Roche Diagnostics 2. Abbott Laboratories 3. Sysmex Corporation 4. Mindray Medical International Limited 5. Shanghai Kehua Bio-Engineering Co. Ltd. 6. bioMérieux SA 7. Bio-Rad Laboratories, Inc 8. Danaher Corporation 9. Thermo Fisher Scientific Inc. 10. Snibe Diagnostic 11. Dirui Medical 12. Autobio Diagnostics 13. YHLO Biotech 14. Beijing Strong Biotechnologies, Inc. 15. Dian Diagnostics Group Co. Ltd. (Formerly Zhejiang Di’an Diagnostics Technology Co., Ltd.) 16. ADICON Clinical Laboratories 17. Guangzhou Kingmed Diagnostics Center Co. Ltd. 18. Kindstar Global 19. BGI-Shenzhen 20. OriGene Technologies